Moreover, HDL-C from T2DM patients with CHD stimulated the release of tumor necrosis factor-α (TNF-α) in monocytes to a greater extent than that of HDL-C from those without CHD, and HDL-C was a significant predictor of the presence of CHD in patients with T2DM [25]. Here, TNF is linked to type 2 diabetes mellitus.